Skip to main content

Table 2 Association of total physical activity with high-density lipoprotein cholesterol and triglyceride levels

From: Total physical activity might not be a good measure in the relationship with HDL cholesterol and triglycerides in a multi-ethnic population: a cross-sectional study

 

European-Dutch

Hindustani-Surinamese

African-Surinamese

Mean HDL

β (95% CI)

β (95% CI)

β (95% CI)

   T1

Reference

Reference

Reference

   T2

0.01 (-0.08, 0.09)

-0.14 (-0.25, -0.03)

0.04 (-0.04, 0.12)

   T3

0.04 (-0.05, 0.13)

0.01 (-0.09, 0.12)

0.08 (0.01, 0.16)

Low HDL in percentage

PR (95% CI)

PR (95% CI)

PR (95% CI)

   T1

Reference = 1

Reference = 1

Reference = 1

   T2

0.94 (0.57, 1.55)

1.45 (0.98, 2.14)

0.73 (0.50, 1.07)

   T3

1.25 (0.76, 2.07)

1.06 (0.71, 1.58)

0.59 (0.40, 0.88)

Triglycerides a

GMR (95% CI)

GMR (95% CI)

GMR (95% CI)

   T1

Reference = 1

Reference = 1

Reference = 1

   T2

1.07 (0.95, 1.20)

1.12 (0.95, 1.33)

0.98 (0.88, 1.10)

   T3

1.07 (0.94, 1.21)

1.01 (0.86, 1.19)

0.91 (0.82, 1.02)

High triglycerides in percentage

PR (95% CI)

PR (95% CI)

PR (95% CI)

   T1

Reference = 1

Reference = 1

Reference = 1

   T2

0.83 (0.54, 1.28)

0.95 (0.59, 1.54)

0.87 (0.49, 1.53)

   T3

1.06 (0.69, 1.61)

0.74 (0.46, 1.18)

0.54 (0.29, 1.02)

  1. CI, confidence interval; GMR, geometric mean ratio; HDL, high-density lipoprotein; PR, prevalence ratio(estimated with robust Poisson regression); T1-T3, tertiles of the total physical activity score. The estimates for β and the GMR are based on a restricted dataset excluding participants with known raised cholesterol and/or triglyceride levels. Estimates are adjusted for age and sex.
  2. aTriglyceride levels were skewed and therefore log-transformed in the model. The values represent the GMRs compared to each reference group. Low HDL cholesterol < 1.04 mmol/L (< 40 mg/dL) for men and < 1.29 mmol/L (< 50 mg/dL) for women. Raised triglycerides ≥1.7 mmol/L (≥150 mg/dL) or receiving cholesterol/triglycerides lowering medication.